 |
1.25.40.70.3.1.1.1.1 |
1he8A03 |
mTOR signaling pathway, Insulin signaling pathway, 1-phosphatidylinositol-3-kinase activity, Phosphatidylinositol-4,5-bisphosphate 3-kinase., Small cell lung cancer, Prostate cancer, Acute myeloid leukemia, Inositol phosphate metabolism, Regulation of actin cytoskeleton, ErbB signaling pathway, Glioma, Pathways in cancer, protein binding, T cell receptor signaling pathway, Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, Homo sapiens, Chemokine signaling pathway, Pancreatic cancer, G-protein coupled receptor protein signaling pathway, Type II diabetes mellitus, Neurotrophin signaling pathway, Leukocyte transendothelial migration, Melanoma, phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153], Aldosterone-regulated sodium reabsorption, B cell receptor signaling pathway, Focal adhesion, Chagas disease, Fc epsilon RI signaling pathway, Jak-STAT signaling pathway, Progesterone-mediated oocyte maturation, Natural killer cell mediated cytotoxicity, Phosphatidylinositol signaling system, Non-small cell lung cancer, Chronic myeloid leukemia, Colorectal cancer, Toll-like receptor signaling pathway, VEGF signaling pathway, Apoptosis, Endometrial cancer, Fc gamma R-mediated phagocytosis, Renal cell carcinoma |
 |